![]() |
市场调查报告书
商品编码
1475207
全球注射包装市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测Global Parenteral Packaging Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032 |
全球注射剂包装市场需求预计将从2023年的102.1亿美元达到2032年近258.9亿美元的市场规模,2024-2032年研究期间复合年增长率为10.89%。
肠胃外包装是指用于无菌包装注射药物、液体和溶液的材料和容器,用于经由消化道以外的途径给药,例如静脉注射、肌肉注射或皮下注射。这些包装系统必须在药品的整个保质期内保持无菌、完整性和稳定性,保护其免受污染、光照和物理损坏。常见的胃肠外包装材料包括玻璃瓶、安瓿、注射器和预填充药筒,以及由聚丙烯、聚乙烯和环烯烃共聚物(COC)等材料製成的塑胶容器和袋子。
慢性病的日益普及、人口老化以及生物製药的进步推动了对透过皮下 (SC) 注射和静脉注射 (IV) 等注射途径给药的肠外药物的需求。随着医疗保健支出的增加、患者群体的扩大以及癌症、糖尿病、自体免疫疾病和传染病注射疗法的日益采用,对注射剂包装解决方案的需求日益增长,以确保整个药物过程中产品的完整性、相容性和病人安全生命週期。此外,包装材料、容器封闭系统和无菌製造流程的进步使得注射包装解决方案的开发成为可能,这些解决方案提供屏障保护、微生物稳定性和防篡改功能,以在储存、运输和运输过程中保持药物的效力、稳定性和无菌性。
此外,随着製药公司寻求能够增强药物依从性、促进自我给药和改善患者治疗效果的包装解决方案,对以患者为中心的包装、用户友好的设计和合规性包装的日益重视推动了市场创新。此外,注射剂包装的监管要求、品质标准和行业指南(例如USP<797>、USP<800> 和ISO 13485)推动了市场合规性、品质保证和产品差异化,因为製造商努力满足监管期望、减轻压力。然而,严格的监管要求、安全标准和合规问题可能会阻碍未来几年的市场成长。
研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外,这些工具也对全球注射剂包装市场的各个细分市场进行了包容性评估。注射剂包装产业的成长和趋势为本研究提供了整体方法。
注射包装市场报告的这一部分提供了国家和区域层面细分市场的详细资料,从而帮助战略家确定相应产品或服务的目标人群以及即将到来的机会。
本节涵盖区域前景,重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肠外包装市场当前和未来的需求。此外,该报告重点关注所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。注射包装市场的主要参与者包括 RPC Group、Unilife Corporation、Gerresheimer AG、Stevanato Group、Berry Plastics Corporation、Nipro Corporation、MeadWestvaco Corporation、Becton Dickinson and Company Inc.、Schott AG、Dickinson and Company Inc.、Ypsomed Holding AG 、Terumo Corporation、SiO2 Medical Products、West Pharmaceutical Services、Schott Pharmaceuticals Services Inc.、Owens-Illinois、Graphic Packaging Group。本节包含竞争格局的整体视图,包括各种策略发展,例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。
如果您有任何客製化要求,请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。
The global demand for Parenteral Packaging Market is presumed to reach the market size of nearly USD 25.89 Billion by 2032 from USD 10.21 Billion in 2023 with a CAGR of 10.89% under the study period 2024 - 2032.
Parenteral packaging refers to the materials and containers used for the sterile packaging injectable drugs, fluids, and solutions intended for administration via routes other than the digestive tract, such as intravenous, intramuscular, or subcutaneous injection. These packaging systems must maintain the sterility, integrity, and stability of the pharmaceutical product throughout its shelf life, protecting it from contamination, light exposure, and physical damage. Common parenteral packaging materials include glass vials, ampules, syringes, and pre-filled cartridges, as well as plastic containers and bags made from materials such as polypropylene, polyethylene, and cyclic olefin copolymer (COC).
The growing prevalence of chronic diseases, aging populations, and advancements in biopharmaceuticals drive the demand for parenteral medications administered via injection routes such as subcutaneous (SC) injections and intravenous (IV). With rising healthcare expenditures, expanding patient populations, and the increasing adoption of injectable therapies for cancer, diabetes, autoimmune diseases, and infectious diseases, there is a growing need for parenteral packaging solutions that ensure product integrity, compatibility, and patient safety throughout the drug lifecycle. Additionally, advancements in packaging materials, container closure systems, and sterile manufacturing processes enable the development of parenteral packaging solutions that offer barrier protection, microbial stability, and tamper-evident features to maintain drug potency, stability, and sterility during storage, transportation, and administration.
Moreover, the increasing emphasis on patient-centric packaging, user-friendly designs, and compliance packaging drives market innovation as pharmaceutical companies seek packaging solutions that enhance medication adherence, facilitate self-administration, and improve patient outcomes. Furthermore, regulatory requirements, quality standards, and industry guidelines for parenteral packagings, such as USP <797>, USP <800>, and ISO 13485, drive market compliance, quality assurance, and product differentiation as manufacturers strive to meet regulatory expectations, mitigate risks, and maintain product safety and efficacy. However, stringent regulatory requirements, safety standards, and compliance issues may hamper market growth in the coming years.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of parenteral packaging. The growth and trends of parenteral packaging industry provide a holistic approach to this study.
This section of the parenteral packaging market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Parenteral Packaging market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Parenteral Packaging market include RPC Group, Unilife Corporation, Gerresheimer AG, Stevanato Group, Berry Plastics Corporation, Nipro Corporation, MeadWestvaco Corporation, Becton Dickinson and Company Inc., Schott AG, Dickinson and Company Inc., Ypsomed Holding AG, Terumo Corporation, SiO2 Medical Products, West Pharmaceutical Services, Schott Pharmaceuticals Services Inc., Owens-Illinois, Graphic Packaging Group. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.